What is the most appropriate first‑line injection for a patient with isolated left anterior and lateral thigh pain radiating to the knee without any back pain?

Diagnostic Injection with Lidocaine to Differentiate Joint vs. Referred Pain

For a patient with isolated anterior and lateral thigh pain radiating to the knee without back pain, the most appropriate first-line injection is a diagnostic lidocaine test into the hip joint under ultrasound or fluoroscopic guidance to determine if this is referred hip pain versus primary thigh pathology. 1

Clinical Reasoning

Why This Presentation Suggests Hip Pathology

• Anterior and lateral thigh pain radiating to the knee is a classic referred pain pattern from hip joint pathology, not a primary thigh condition requiring local injection 1
• The absence of back pain makes lumbar radiculopathy less likely, though L2-L3 pathology can present similarly
• True thigh muscle or soft tissue pathology typically presents with localized tenderness, not radiation to the knee

The Diagnostic Approach

A lidocaine test injection into the hip joint serves to identify the origin of pain and distinguish joint versus referred pain. 1 This is explicitly recommended by EULAR guidelines as a diagnostic tool when the pain source is unclear 1

• Hip injections must be performed under imaging guidance (ultrasound or fluoroscopy) due to joint depth and proximity to neurovascular structures 1
• If the lidocaine injection provides immediate pain relief (within 15-30 minutes), this confirms the hip as the pain source
• If no relief occurs, consider alternative diagnoses including lumbar spine pathology, meralgia paresthetica, or primary muscle pathology

Therapeutic Injection After Diagnosis

If Hip Joint is Confirmed as Pain Source

Once hip pathology is confirmed via diagnostic injection, proceed with intra-articular corticosteroid injection for therapeutic benefit. 1

• Intra-articular glucocorticoid injections are strongly recommended for hip osteoarthritis with demonstrated short-term efficacy in pain reduction and functional improvement 1
• Long-acting corticosteroid preparations (triamcinolone or methylprednisolone) provide benefit for 4-24 weeks 1
• All hip injections require imaging guidance—this is a strong recommendation, not optional 1

Common Pitfalls to Avoid

• Do not perform blind hip injections—the depth of the joint and neurovascular proximity make imaging guidance mandatory 1
• Do not inject corticosteroids without first establishing a diagnosis, as EULAR explicitly warns against administering intra-articular steroids before appropriate diagnosis 1
• Avoid assuming this is a primary thigh condition requiring trigger point or soft tissue injection without first ruling out referred hip pain
• If the patient is diabetic, counsel about transient hyperglycemia risk for 1-3 days post-corticosteroid injection and advise glucose monitoring 1

Alternative Diagnoses to Consider

If the diagnostic hip injection provides no relief:

• Meralgia paresthetica (lateral femoral cutaneous nerve entrapment)—presents with anterolateral thigh pain/numbness
• L2-L3 radiculopathy—can cause anterior thigh pain without prominent back pain
• Iliopsoas bursitis or tendinopathy—may require separate targeted injection
• Femoral nerve pathology—though typically includes weakness and reflex changes

Post-Injection Management

• Advise patients to avoid overuse of the injected joint for 24 hours, but do not immobilize 1
• Monitor for adverse effects including infection risk (rare with proper aseptic technique) 1
• The decision to reinject should consider benefits from previous injections and be made through shared decision-making 1
• Corticosteroid injections should be avoided within 3 months of planned joint replacement surgery 1